Azenta (AZTA) Net Equity Issued and Repurchased (2010 - 2026)
Azenta's (AZTA) quarterly Net Equity Issued and Repurchased came in at $1.2 million in Q1 2026, down 3.12% on a QoQ basis from $1.2 million in Q3 2025.
Azenta (AZTA) Net Equity Issued and Repurchased (2010 - 2026) Analysis & Trends
Azenta (AZTA) has 15 years of Net Equity Issued and Repurchased data on file, last reported at $1.2 million in Q1 2026.
- On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $1.2 million in Q1 2026; TTM through Mar 2026 was $4.0 million, a N/A change from a year earlier, with the FY2025 full-year figure at $2.8 million, down 15.52% from the prior year.
- Net Equity Issued and Repurchased for Q1 2026 stood at $1.2 million, down from $1.2 million in the prior quarter.
- Over the last five years, Net Equity Issued and Repurchased for AZTA reached as high as $1.8 million in Q3 2022 and fell as low as $1.2 million in Q1 2026.
- Historically, Net Equity Issued and Repurchased has averaged $1.5 million across 5 years, with a median of $1.6 million in 2024.
- Across the five-year window, Net Equity Issued and Repurchased slumped 44.75% in 2022 and retreated 0.84% in 2023, its largest moves.
- Year by year, Net Equity Issued and Repurchased stood at $1.8 million in 2022, then dropped by 0.84% to $1.8 million in 2023, then fell by 9.5% to $1.6 million in 2024, then declined by 23.99% to $1.2 million in 2025, then slipped by 3.12% to $1.2 million in 2026.
- Per Business Quant data, the three most recent Net Equity Issued and Repurchased figures were $1.2 million in Q1 2026, $1.2 million in Q3 2025, and $1.6 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | - |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | - |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 7.43 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | - |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | - |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 11.72 Mn |
| 10 | Azenta | 1.30 Bn | 1.07 Bn | 125.74 Mn | 1.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.18 Mn |
| Mar 31, 2026 | 1.18 Mn |
| Sep 30, 2025 | 1.22 Mn |
| Sep 30, 2025 | 1.22 Mn |
| Sep 30, 2024 | 1.60 Mn |
| Sep 30, 2024 | 1.60 Mn |
| Sep 30, 2023 | 1.77 Mn |
| Sep 30, 2023 | 1.77 Mn |
| Sep 30, 2022 | 1.78 Mn |
| Sep 30, 2022 | 1.78 Mn |
| Sep 30, 2021 | 3.23 Mn |
| Sep 30, 2021 | 3.23 Mn |
| Sep 30, 2020 | 2.26 Mn |
| Sep 30, 2020 | 2.26 Mn |
| Jun 30, 2020 | 2,000.00 |
| Jun 30, 2020 | 2,000.00 |
| Sep 30, 2019 | 1.87 Mn |
| Sep 30, 2019 | 1.87 Mn |
| Sep 30, 2018 | 1.43 Mn |
| Sep 30, 2018 | 1.43 Mn |